Published online
doi:10.1084/jem.20062076
The Journal of Experimental Medicine, Vol. 204, No. 6, 1327-1334
The Rockefeller University Press, 0022-1007 $30.00
© Yuan et al.
CCR4-dependent regulatory T cell function in inflammatory bowel disease
Qian Yuan1,2,
Shannon K. Bromley1,
Terry K. Means1,
Krister J. Jones1,2,
Fumitaka Hayashi1,
Atul K. Bhan3, and
Andrew D. Luster1
1 Division of Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases; 2 Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics; and 3 Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114
CORRESPONDENCE Andrew D. Luster: luster.andrew{at}mgh.harvard.edu
Inflammatory bowel disease (IBD) is an idiopathic inflammatory disease of the intestine. CD4+ T lymphocytes play an important role in both initiating and regulating intestinal inflammatory immune responses. CD4+CD25+CD45RBlow regulatory T (T reg) cells are capable of preventing the development of colitis in a mouse model of IBD. The precise mechanism of T reg cell–mediated prevention of colitis in this model is unclear, and the role of chemokine receptors in the trafficking and function of T reg cells in this model has not been determined. We examined the role of the chemokine receptor CCR4 in in vivo trafficking and suppressive function of T reg cells in a mouse adoptive transfer model of IBD. CCR4-deficient T reg cells failed to accumulate in the mesenteric lymph nodes (MLNs) at early time points (2–5 d) after adoptive transfer, resulting in a failure to suppress the generation of pathogenic T cells and the development of colitis. Moreover, although CCR4-deficent T cells had equivalent in vitro suppressive activity and accumulated in MLNs at later time points (42–56 d), they were unable to suppress colitis. Our study demonstrates that CCR4 plays an important role in T reg cell trafficking in LNs and that this is critical for T reg cell suppressive function in vivo.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Wang, S. H., Chen, G.-H., Fan, Y., Van Antwerp, M., Baker, J. R. Jr.
(2009). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Experimental Autoimmune Thyroiditis by the Expansion of CD4+CD25+ Regulatory T Cells. Endocrinology
150: 2000-2007
[Abstract]
[Full Text]
-
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., Perez, S., Pasqual, N., Faure, C., Ray-Coquard, I., Puisieux, A., Caux, C., Blay, J.-Y., Menetrier-Caux, C.
(2009). Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome. Cancer Res.
69: 2000-2009
[Abstract]
[Full Text]
-
Abe, J., Ueha, S., Suzuki, J., Tokano, Y., Matsushima, K., Ishikawa, S.
(2008). Increased Foxp3+ CD4+ Regulatory T Cells with Intact Suppressive Activity but Altered Cellular Localization in Murine Lupus. Am. J. Pathol.
173: 1682-1692
[Abstract]
[Full Text]
-
Muthuswamy, R., Urban, J., Lee, J.-J., Reinhart, T. A., Bartlett, D., Kalinski, P.
(2008). Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation. Cancer Res.
68: 5972-5978
[Abstract]
[Full Text]
-
Guo, Z., Jang, M. H., Otani, K., Bai, Z., Umemoto, E., Matsumoto, M., Nishiyama, M., Yamasaki, M., Ueha, S., Matsushima, K., Hirata, T., Miyasaka, M.
(2008). CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Int Immunol
20: 307-315
[Abstract]
[Full Text]
-
Larkin, J. III, Rankin, A. L., Picca, C. C., Riley, M. P., Jenks, S. A., Sant, A. J., Caton, A. J.
(2008). CD4+CD25+ Regulatory T Cell Repertoire Formation Shaped by Differential Presentation of Peptides from a Self-Antigen. J. Immunol.
180: 2149-2157
[Abstract]
[Full Text]